Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 43 countries.
External link for Medpace
5375 Medpace Way
Cincinnati, OH 45227, US
It's the first #MedpaceMonday of 2025! We are welcoming in the new year with our #MedpaceAthletes. Medpace is thrilled to continue our partnership with Bearcat Athletics as we work to advance the health of millions around the globe through clinical research. Join our extensive network of UC alumni and apply for your next role: https://bit.ly/3YWjlHH #WorkAtMedpace
Season’s greetings from Medpace! As we reflect on a year of innovation and collaboration, we extend our gratitude to the biotech and pharmaceutical community for trusting us to advance the next breakthroughs in clinical research. Wishing you a joyful holiday season and continued success in the year ahead.
Rado Yordanov, Senior Regulatory Submissions Manager at Medpace, shares advice in our latest #careers blog on leadership and curating seamless collaboration among his team. Access the full Q+A now: https://bit.ly/4ip1gce #WorkAtMedpace
As many of our Medpace offices prepare for the winter season, offices like Medpace Brazil welcome in summer! Our Brazil office recently hosted a team bonding event for members both new and tenured to connect. Interested in joining our team in Brazil? Check out open roles and apply today: https://bit.ly/3VQy2cS #WorkAtMedpace #MedpaceBrazil #espíritodeequipe
Semana passada tivemos uma manhã para desconectar do escritório e conectar com a equipe! 💫 Começamos o dia com um café da manhã delicioso e muita conversa boa, e depois partimos pra um jogo de vôlei cheio de energia, diversão e espírito de equipe! 🏐 Momentos como esse reforçam a importância de construir relacionamentos, celebrar conquistas e lembrar que, além de colegas de trabalho, somos um time. Obrigada à todos que participaram e fizeram desse dia tão especial! 👏 ************************************************************************************ Last week we had a morning to disconnect from the office and connect with the team! 💫 We started the day with a delicious breakfast and lots of good conversation, and then we head off to a volleyball game full of energy, fun and team spirit! 🏐 Moments like these reinforce the importance of building relationships, celebrating achievements and remembering that, in addition to being co-workers, we are a team. Thank you to everyone who participated and made this day so special! 👏 #teambuilding #espíritodeequipe #corporateculture #culturacorporativa #medpace #medpacebrazil
Approximately 56.9 million people worldwide are living with #Alzheimer’s Disease and other dementias, projected to rise to 78 million by 2030. With few approved and effective therapeutic interventions available, there is an urgent need for new treatment options to address the profound impact on patients, families, and society. Download this article to explore the challenges of AD and #neurodegenerative clinical trials, recent successes in the field, and strategies for achieving success in these trials: https://lnkd.in/gHevTguM
As Medpace's Executive Director of Clinical Packaging & Supplies, Mary Ellen Weber not only built her department from the ground up, but also established a mentorship structure to support entry-level associates. Learn more about how her #leadership shaped a vital team at Medpace in our latest #careers blog post. Check out the full Q+A: https://bit.ly/4ip1gce #WorkAtMedpace #Mentorship
The insights emerging from #ASH2024 provide a pivotal roadmap for biopharma companies aiming to stay at the forefront of #hematology innovation. From advancing therapeutic scalability to optimized clinical trial designs, the data presented offers an opportunity to refine clinical strategies, enhance patient access, and shorten development timelines. “Congratulations to the Investigators and Sponsors whose groundbreaking data at ASH 2024 is advancing hematology research. Medpace is proud to partner with biopharma to bring innovative therapies to patients in need and looks forward to driving progress in the year ahead," shares Dr. Blythe Thomson, Senior Vice President of Hematology and Oncology at Medpace. Stay ahead of the curve—explore insights designed to empower biopharma success: https://lnkd.in/gtBYtmKk
Explore career breakthroughs at Medpace! In our latest #careers blog post, Nick O'Hanlon, Clinical Research Associate, shares advice and describes how he and his team are driving the development of clinical research through collaboration. Read the the full Q+A: https://bit.ly/4ip1gce #WorkAtMedpace
In the final video of the series, Maria Beatriz (Bia) Michelini, Ph.D. and Juliana Polachini de Castro share key aspects of the Medpace infectious diseases and vaccines clinical operations team in Latin America, specializing in the design and execution of global trials for antivirals, antibacterials, antifungals, vaccines, and immunotherapies. Our infectious diseases experts have country and region-specific expertise, allowing us to seamlessly integrate local language, culture, and requirements into study conduct. Learn more about Medpace's clinical development capabilities in #InfectiousDiseases and #Vaccines: https://lnkd.in/g-Z8FfPd
Interested in breaking into the clinical research industry? Sonia Lourdes, Associate Clinical Trial Manager, shares her experience joining our Medpace Australia office in our latest #careers blog. Get insights into Sonia's journey and the training and mentorship she received. Read the the full Q+A here: https://bit.ly/4ip1gce #WorkAtMedpace #ClinicalResearch
MEDP
NASDAQ
20 minutes delay
$342.07
2.61 (0.769%)
Data from Refinitiv
See more info on